Digital Health Roundup, 12 October 2021 – Record-Breaking Funding; FDA, AAOS 2021

In this month’s podcast, Medtech Insight's Reed Miller and Marion Webb provide a recap of our digital health coverage in August and September, including start-ups that grabbed new funding, news from AAOS 2021 and regulatory news. Medtech Insight articles addressing topics discussed in this episode: Akili Pays $37.5M To License Tali’s Tech For Early Childhood Attention Impairments https://medtech.pharmaintelligence.informa.com/MT144365/Akili-Pays-375M-To-License-Talis-Tech-For-Early-Childhood-Attention-Impairments Hagar Lands Funding To Develop Noninvasive Glucose Monitoring Watch https://medtech.pharmaintelligence.informa.com/MT144335/Hagar-Lands-Funding-To-Develop-Noninvasive-Glucose-Monitoring-Watch Flywheel.io Raises $22M And Buys Out Competition https://medtech.pharmaintelligence.informa.com/MT144463/Flywheelio-Raises-22M-And-Buys-Out-Competition Zoll Medical Signs Definite Agreement To Buy Itamar Medical For $538M https://medtech.pharmaintelligence.informa.com/MT144453/Zoll-Medical-Signs-Definite-Agreement-To-Buy-Itamar-Medical-For-$538M A Closer Look At Think Surgical’s Active Open Implant Orthopedic Robot and What’s Ahead https://medtech.pharmaintelligence.informa.com/MT144506/AAOS-2021-A-Closer-Look-At-Think-Surgicals-Active-OpenImplant-Orthopedic-Robot-And-Whats-Ahead Zimmer Biomet Canary Medical Win FDA De Novo For First Smart Knee Implant https://medtech.pharmaintelligence.informa.com/MT144400/Zimmer-Biomet-Canary-Medical-Win-FDA-De-Novo-For-First-Smart-Knee-Implant Exec Chat: AAOS 2021 Outgoing President Bosco Discusses Hot-Button-Issues – Inpatient-Only List, Pre-Authorization, New Tech https://medtech.pharmaintelligence.informa.com/MT144412/Exec-Chat-AAOS-2021-Outgoing-President-Bosco-Discusses-HotButton-Issues--InpatientOnly-List-PreAuthorization-New-Tech Market Intel: Robotic Surgery Holds Great Promise, But Is Not Quite There Yet https://medtech.pharmaintelligence.informa.com/MT144388/Market-Intel-Robotic-Surgery-Holds-Great-Promise-But-Is-Not-Quite-There-Yet New FDA Web Page Spotlights